Loading...
Market
What will Terns Pharmaceuticals' stock price be at the end of 2024?
2
Resolution / Starting Odds
Above $25 • 25%
$20 - $25 • 25%
$15 - $20 • 25%
Below $15 • 25%
Stock market data from financial websites like Yahoo Finance, Bloomberg
Story
Terns Pharmaceuticals Stock Soars 10% After Positive Phase 1 Trial Results Showing 5.5% Weight Loss
Sep 9, 2024, 11:09 AM
Terns Pharmaceuticals has announced positive Phase 1 clinical trial results for its once-daily oral GLP-1R agonist, TERN-601, aimed at treating obesity. The trial demonstrated a statistically significant mean weight loss of up to 5.5% over 28 days, with a 4.9% placebo-adjusted weight loss. The study also reported the absence of treatment-related dose interruptions, reductions, or discontinuations, with mostly mild adverse events, despite aggressive titration to high doses. Following this announcement, Terns Pharmaceuticals' stock soared by 10%.
View original story
Similar markets
Less than $20 • 25%
$20 to $30 • 25%
$30 to $40 • 25%
More than $40 • 25%
Below $25 • 25%
$25 - $50 • 25%
$50 - $75 • 25%
Above $75 • 25%
Below $2 • 25%
$2 to $5 • 25%
Above $10 • 25%
Below $5 • 25%
$5 to $10 • 25%
$10 to $15 • 25%
Above $15 • 25%
Above $25 • 25%
$20-$25 • 25%
$15-$20 • 25%
Below $15 • 25%
Yes • 50%
No • 50%
Below $5 • 25%
$5 to $7 • 25%
$7 to $9 • 25%
Above $9 • 25%
Increase by 20% or more • 25%
Increase by less than 20% • 25%
Remain about the same • 25%
Decrease • 25%
Above $100 • 25%
$75 to $100 • 25%
$50 to $75 • 25%
Below $50 • 25%
Less than 50% • 25%
50% to 100% • 25%
100% to 200% • 25%
More than 200% • 25%
Above $10 • 25%
$8 to $10 • 25%
$6 to $8 • 25%
Below $6 • 25%
Below $60 • 25%
$60-$70 • 25%
$70-$80 • 25%
Above $80 • 25%